To include your compound in the COVID-19 Resource Center, submit it here.

Jazz gains on earnings

Jazz Pharmaceuticals Inc. (NASDAQ:JAZZ) gained $5.20 (15%) to $40.47

Read the full 98 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE